WINTON GROUP LTD – Neurocrine Biosciences, Inc. Transaction History
WINTON GROUP LTD portfolio value:
$4.89M
portfolio value
WINTON GROUP LTD quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.58% | 2.84K shares | 680K | $106.21 | 46.12K |
| Q2 2022 | share | Increase | +18.55% | 6.77K shares | 796K | $97.48 | 43.28K |
| Q1 2022 | share | Decrease | -9.77% | -3.95K shares | -23K | $93.75 | 36.50K |
| Q4 2021 | share | Increase | +97.33% | 19.95K shares | 1.47M | $84.63 | 40.46K |
| Q3 2021 | share | Decrease | -5.89% | -1.28K shares | -153K | $95.91 | 20.50K |
| Q2 2021 | share | Decrease | -4.20% | -955 shares | -92K | $97.32 | 21.78K |
| Q1 2021 | share | Increase | +5.40% | 1.16K shares | 144K | $97.25 | 22.74K |
| Q4 2020 | share | Decrease | -66.10% | -42.07K shares | -4.05M | $95.85 | 21.57K |
| Q3 2020 | share | Increase | +14.68% | 8.14K shares | -650K | $96.16 | 63.65K |
| Q2 2020 | share | Increase | +34.91% | 14.36K shares | 3.21M | $122 | 55.50K |
| Q1 2020 | share | Increase | +22.28% | 7.49K shares | -55K | $86.55 | 41.14K |
| Q4 2019 | share | Increase | +156.06% | 20.50K shares | 2.43M | $107.49 | 33.64K |
| Q3 2019 | share | Increase | 0.00% | 13.13K shares | 1.18M | $90.11 | 13.13K |
| Q2 2019 | share | Decrease | -100.00% | -4.47K shares | -394K | $84.43 | 0 |
| Q1 2019 | share | Decrease | -23.42% | -1.36K shares | -23K | $88.1 | 4.47K |
| Q4 2018 | share | Decrease | -3.73% | -226 shares | -329K | $71.41 | 5.83K |
| Q3 2018 | share | Decrease | -0.88% | -54 shares | 145K | $122.95 | 6.06K |
| Q2 2018 | share | Decrease | -35.44% | -3.35K shares | -185K | $98.24 | 6.11K |
| Q1 2018 | share | Increase | 0.00% | 9.47K shares | 786K | $82.93 | 9.47K |